National Research Corporation (NRC)
USD 12.77
(5.41%)
USD 12.77
(5.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 40.04 Million USD | -13.87% |
| 2022 | 46.54 Million USD | -7.41% |
| 2021 | 50.27 Million USD | 17.79% |
| 2020 | 42.67 Million USD | -0.83% |
| 2019 | 43.03 Million USD | 22.0% |
| 2018 | 35.27 Million USD | 3.09% |
| 2017 | 34.21 Million USD | 9.69% |
| 2016 | 31.19 Million USD | 17.96% |
| 2015 | 26.44 Million USD | -6.53% |
| 2014 | 28.29 Million USD | 14.07% |
| 2013 | 24.8 Million USD | 9.19% |
| 2012 | 22.71 Million USD | 21.27% |
| 2011 | 18.73 Million USD | 35.2% |
| 2010 | 13.85 Million USD | 1.17% |
| 2009 | 13.69 Million USD | 14.25% |
| 2008 | 11.98 Million USD | 5.49% |
| 2007 | 11.36 Million USD | 14.71% |
| 2006 | 9.9 Million USD | 17.74% |
| 2005 | 8.41 Million USD | 13.69% |
| 2004 | 7.4 Million USD | 6.27% |
| 2003 | 6.96 Million USD | 8.51% |
| 2002 | 6.41 Million USD | 136.64% |
| 2001 | 2.71 Million USD | -18.41% |
| 2000 | 3.32 Million USD | 58.31% |
| 1999 | 2.1 Million USD | -32.26% |
| 1998 | 3.1 Million USD | -36.73% |
| 1997 | 4.9 Million USD | 36.11% |
| 1996 | 3.6 Million USD | 22.49% |
| 1995 | 2.93 Million USD | 77.26% |
| 1994 | 1.65 Million USD | 224.46% |
| 1993 | 511 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 8.79 Million USD | -24.9% |
| 2024 Q2 | 8.86 Million USD | 0.81% |
| 2024 Q3 | 7.98 Million USD | -9.98% |
| 2023 Q3 | 9.95 Million USD | 6.3% |
| 2023 Q4 | 11.7 Million USD | 17.62% |
| 2023 FY | 40.08 Million USD | -13.87% |
| 2023 Q1 | 9.01 Million USD | -26.35% |
| 2023 Q2 | 9.36 Million USD | 3.87% |
| 2022 Q4 | 12.24 Million USD | 10.19% |
| 2022 Q2 | 11.49 Million USD | -1.72% |
| 2022 FY | 46.54 Million USD | -7.41% |
| 2022 Q1 | 11.69 Million USD | -9.14% |
| 2022 Q3 | 11.1 Million USD | -3.37% |
| 2021 Q1 | 12.02 Million USD | 17.99% |
| 2021 FY | 50.27 Million USD | 17.79% |
| 2021 Q2 | 12.23 Million USD | 1.82% |
| 2021 Q4 | 12.87 Million USD | -2.02% |
| 2021 Q3 | 13.13 Million USD | 7.35% |
| 2020 Q1 | 11.19 Million USD | -6.42% |
| 2020 Q2 | 9.27 Million USD | -17.14% |
| 2020 Q3 | 12.02 Million USD | 29.61% |
| 2020 Q4 | 10.18 Million USD | -15.26% |
| 2020 FY | 42.67 Million USD | -0.83% |
| 2019 Q1 | 10.7 Million USD | 13.93% |
| 2019 Q2 | 10.14 Million USD | -5.18% |
| 2019 Q3 | 10.22 Million USD | 0.7% |
| 2019 Q4 | 11.96 Million USD | 17.05% |
| 2019 FY | 43.03 Million USD | 22.0% |
| 2018 Q4 | 9.39 Million USD | 2.5% |
| 2018 Q3 | 9.16 Million USD | 18.18% |
| 2018 FY | 35.27 Million USD | 3.09% |
| 2018 Q2 | 7.75 Million USD | -13.42% |
| 2018 Q1 | 8.95 Million USD | 3.43% |
| 2017 Q1 | 9.98 Million USD | 13.02% |
| 2017 FY | 34.21 Million USD | 9.69% |
| 2017 Q4 | 8.66 Million USD | 21.61% |
| 2017 Q3 | 7.12 Million USD | -15.74% |
| 2017 Q2 | 8.45 Million USD | -15.34% |
| 2016 Q3 | 7.33 Million USD | 4.57% |
| 2016 FY | 31.19 Million USD | 17.96% |
| 2016 Q2 | 7.01 Million USD | -12.34% |
| 2016 Q1 | 8 Million USD | 3.89% |
| 2016 Q4 | 8.83 Million USD | 20.37% |
| 2015 Q4 | 7.7 Million USD | 17.68% |
| 2015 Q2 | 6.36 Million USD | 9.18% |
| 2015 Q1 | 5.82 Million USD | -9.19% |
| 2015 FY | 26.44 Million USD | -6.53% |
| 2015 Q3 | 6.54 Million USD | 2.89% |
| 2014 Q4 | 6.41 Million USD | -10.34% |
| 2014 FY | 28.29 Million USD | 14.07% |
| 2014 Q3 | 7.15 Million USD | 13.31% |
| 2014 Q2 | 6.31 Million USD | -24.79% |
| 2014 Q1 | 8.4 Million USD | 39.37% |
| 2013 Q2 | 5.53 Million USD | -23.32% |
| 2013 Q1 | 7.21 Million USD | 24.99% |
| 2013 FY | 24.8 Million USD | 9.19% |
| 2013 Q4 | 6.02 Million USD | -0.03% |
| 2013 Q3 | 6.02 Million USD | 8.94% |
| 2012 Q2 | 5.21 Million USD | -14.24% |
| 2012 Q3 | 5.64 Million USD | 8.26% |
| 2012 FY | 22.71 Million USD | 21.27% |
| 2012 Q4 | 5.77 Million USD | 2.25% |
| 2012 Q1 | 6.08 Million USD | 21.4% |
| 2011 Q1 | 5.7 Million USD | 141.63% |
| 2011 Q2 | 3.83 Million USD | -32.79% |
| 2011 Q3 | 4.19 Million USD | 9.48% |
| 2011 Q4 | 5.01 Million USD | 19.46% |
| 2011 FY | 18.73 Million USD | 35.2% |
| 2010 FY | 13.85 Million USD | 1.17% |
| 2010 Q1 | 5.34 Million USD | 60.86% |
| 2010 Q2 | 2.65 Million USD | -50.29% |
| 2010 Q3 | 3.49 Million USD | 31.41% |
| 2010 Q4 | 2.35 Million USD | -32.46% |
| 2009 Q2 | 2.7 Million USD | -38.22% |
| 2009 FY | 13.69 Million USD | 14.25% |
| 2009 Q4 | 3.32 Million USD | 0.79% |
| 2009 Q3 | 3.29 Million USD | 22.06% |
| 2009 Q1 | 4.37 Million USD | 47.12% |
| 2008 Q1 | 3.3 Million USD | 81.42% |
| 2008 FY | 11.98 Million USD | 5.49% |
| 2008 Q2 | 2.55 Million USD | -22.55% |
| 2008 Q4 | 2.97 Million USD | -5.82% |
| 2008 Q3 | 3.15 Million USD | 23.46% |
| 2007 Q1 | 2.72 Million USD | 45.63% |
| 2007 FY | 11.36 Million USD | 14.71% |
| 2007 Q4 | 1.81 Million USD | -55.72% |
| 2007 Q3 | 4.11 Million USD | 51.91% |
| 2007 Q2 | 2.7 Million USD | -0.87% |
| 2006 Q2 | 2.14 Million USD | 12.7% |
| 2006 Q1 | 1.9 Million USD | -17.97% |
| 2006 Q3 | 3.99 Million USD | 86.42% |
| 2006 Q4 | 1.87 Million USD | -53.05% |
| 2006 FY | 9.9 Million USD | 17.74% |
| 2005 Q1 | 1.23 Million USD | -12.05% |
| 2005 Q2 | 1.53 Million USD | 23.9% |
| 2005 Q4 | 2.31 Million USD | -30.38% |
| 2005 FY | 8.41 Million USD | 13.69% |
| 2005 Q3 | 3.32 Million USD | 116.92% |
| 2004 Q4 | 1.4 Million USD | -49.44% |
| 2004 Q3 | 2.78 Million USD | 111.58% |
| 2004 Q2 | 1.31 Million USD | -30.58% |
| 2004 Q1 | 1.89 Million USD | -0.81% |
| 2004 FY | 7.4 Million USD | 6.27% |
| 2003 Q1 | 1.51 Million USD | -24.44% |
| 2003 FY | 6.96 Million USD | 8.51% |
| 2003 Q4 | 1.91 Million USD | -8.87% |
| 2003 Q3 | 2.09 Million USD | 45.0% |
| 2003 Q2 | 1.44 Million USD | -4.4% |
| 2002 Q4 | 2 Million USD | -14.02% |
| 2002 Q3 | 2.32 Million USD | 53.74% |
| 2002 Q1 | 575.8 Thousand USD | 56.86% |
| 2002 FY | 6.41 Million USD | 136.64% |
| 2002 Q2 | 1.51 Million USD | 162.95% |
| 2001 Q3 | 1.52 Million USD | 1863.49% |
| 2001 FY | 2.71 Million USD | -18.41% |
| 2001 Q4 | 367.08 Thousand USD | -75.9% |
| 2001 Q1 | 744.75 Thousand USD | -25.51% |
| 2001 Q2 | 77.57 Thousand USD | -89.58% |
| 2000 Q3 | 1.01 Million USD | 37.3% |
| 2000 FY | 3.32 Million USD | 58.31% |
| 2000 Q4 | 999.74 Thousand USD | -1.39% |
| 2000 Q2 | 738.4 Thousand USD | 28.95% |
| 2000 Q1 | 572.62 Thousand USD | -52.28% |
| 1999 Q2 | 100 Thousand USD | -50.0% |
| 1999 Q1 | 200 Thousand USD | -75.0% |
| 1999 Q4 | 1.2 Million USD | 50.0% |
| 1999 Q3 | 800 Thousand USD | 700.0% |
| 1999 FY | 2.1 Million USD | -32.26% |
| 1998 Q4 | 800 Thousand USD | -11.11% |
| 1998 Q3 | 900 Thousand USD | 28.57% |
| 1998 Q2 | 700 Thousand USD | 16.67% |
| 1998 Q1 | 600 Thousand USD | 108.82% |
| 1998 FY | 3.1 Million USD | -36.73% |
| 1997 FY | 4.9 Million USD | 36.11% |
| 1997 Q1 | 3.4 Million USD | 0.0% |
| 1997 Q2 | 3.5 Million USD | 2.94% |
| 1997 Q4 | -6.8 Million USD | -244.68% |
| 1997 Q3 | 4.7 Million USD | 34.29% |
| 1996 FY | 3.6 Million USD | 22.49% |
| 1995 FY | 2.93 Million USD | 77.26% |
| 1994 FY | 1.65 Million USD | 224.46% |
| 1993 FY | 511 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Accolade, Inc. | -114.45 Million USD | 134.988% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | 846.061% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 72.792% |
| CareCloud, Inc. | -47.11 Million USD | 184.994% |
| CareMax, Inc. | -656.15 Million USD | 106.103% |
| Definitive Healthcare Corp. | -329.8 Million USD | 112.142% |
| Health Catalyst, Inc. | -126.89 Million USD | 131.557% |
| iCoreConnect Inc. | -10.27 Million USD | 489.672% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 44.157% |
| Omnicell, Inc. | -34.86 Million USD | 214.847% |
| Progyny, Inc. | 62.18 Million USD | 35.602% |
| R1 RCM Inc. | 147.9 Million USD | 72.924% |
| Schrödinger, Inc. | -177.44 Million USD | 122.567% |
| Simulations Plus, Inc. | 6.13 Million USD | -553.156% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | 303.822% |
| SCWorx Corp. | -1.45 Million USD | 2860.464% |
| Sharecare, Inc. | -96.47 Million USD | 141.508% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | 846.061% |
| SOPHiA GENETICS SA | -74.82 Million USD | 153.517% |
| TruBridge, Inc. | -42.6 Million USD | 193.994% |
| Nutex Health, Inc. | -31.77 Million USD | 226.032% |
| Renalytix Plc | -29.6 Million USD | 235.251% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 98.355% |
| Aclarion, Inc. | -4.87 Million USD | 921.271% |
| Forian Inc. | -5.59 Million USD | 815.727% |
| HeartBeam, Inc. | -15.31 Million USD | 361.493% |
| GeneDx Holdings Corp. | -163.66 Million USD | 124.468% |
| GoodRx Holdings, Inc. | -27 Million USD | 248.276% |
| HealthEquity, Inc. | 128.13 Million USD | 68.748% |
| 10x Genomics, Inc. | -265.32 Million USD | 115.093% |
| Zhongchao Inc. | -13.28 Million USD | 401.457% |
| HealthStream, Inc. | 16.01 Million USD | -149.984% |
| Augmedix, Inc. | -18.77 Million USD | 313.244% |
| MSP Recovery, Inc. | -559.87 Million USD | 107.153% |
| Spok Holdings, Inc. | 21.22 Million USD | -88.642% |
| Privia Health Group, Inc. | 20.64 Million USD | -93.932% |
| EUDA Health Holdings Limited | -3.96 Million USD | 1110.968% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 72.792% |
| Sharecare, Inc. | -96.47 Million USD | 141.508% |
| Premier, Inc. | 157.08 Million USD | 74.508% |
| Certara, Inc. | -40.77 Million USD | 198.212% |
| GeneDx Holdings Corp. | -163.66 Million USD | 124.468% |
| Ontrak, Inc. | -20.67 Million USD | 293.688% |
| SHL Telemedicine Ltd. | -9 Million USD | 544.648% |
| CareCloud, Inc. | -47.11 Million USD | 184.994% |
| OneMedNet Corporation | -8.37 Million USD | 578.192% |
| HeartBeam, Inc. | -15.31 Million USD | 361.493% |
| EUDA Health Holdings Limited | -3.96 Million USD | 1110.968% |
| CareCloud, Inc. | -47.11 Million USD | 184.994% |
| Mangoceuticals, Inc. | -9.21 Million USD | 534.38% |
| CareMax, Inc. | -656.15 Million USD | 106.103% |
| Healthcare Triangle, Inc. | -11.34 Million USD | 452.882% |
| Aclarion, Inc. | -4.87 Million USD | 921.271% |
| OptimizeRx Corporation | -26.4 Million USD | 251.676% |